ECM-associated proteoglycans may also be critically involved in the pathogenesis of MM as suggested by the fact that multivariate analyses indicate that reduced levels of Decorin are less favourable than high levels of the proteoglycan for optimal treatment responses of MM patients [121]. This evidence concerns the gene DCN and Miyoshi myopathy.